title: The Effects of Mipomersen on Inhibiting Hepatic VLDL Apolipoprotein B100 Synthesis and Propensity for Hepatic Steatosis.
authors.affiliation: Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa;
authors.forename: Frederick J
authors.initials: FJ
authors.lastname: Raal
authors.affiliation: Metabolic and Atherosclerosis Research Center, Cincinnati, OH. esteinmrl@aol.com.
authors.forename: Evan A
authors.initials: EA
authors.lastname: Stein
mesh_terms: D053299:Apolipoprotein B-100; D005234:Fatty Liver; D006801:Humans; D008099:Liver / Q000187:drug effects; D009841:Oligonucleotides
chemical_list: D053299:Apolipoprotein B-100; D009841:Oligonucleotides; C524142:mipomersen